|
Kristen Hege, M.D. was promoted to the position of vice president, clinical research in July, 2004. Dr. Hege first joined Cell Genesys in January of 1994 as a medical post-doctoral research fellow, working on preclinical studies of hematopoietic stem cell gene therapy. For the past 8 years she has worked in the clinical research department, most recently as senior director, clinical research. Dr. Hege participated in the first clinical trial ever performed at the company and since then has overseen many of the clinical programs, including GVAX® cancer vaccines and T cell gene therapy for cancer and HIV infection. In addition to her work at Cell Genesys, Dr. Hege has held a clinical faculty appointment at UCSF since 1997 in the adult leukemia and bone marrow transplant program. Dr. Hege received a B.A. in biochemistry summa cum laude from Dartmouth College and an M.D. from the University of California, San Francisco. She is a member of the Phi Beta Kappa and Alpha Omega Alpha academic honor societies. She received her subspecialty training at Harvard Medical School and UCSF and is board certified in Hematology and Oncology.
| 